# Apellis Stock Volatility

APLS | Stock | ## USD 50.36 2.84 5.98% |

Apellis Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.087, which signifies that the company had -0.087% of return per unit of standard deviation over the last 3 months. Macroaxis philosophy in foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Apellis Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Apellis Pharmaceuticals risk adjusted performance of (0.09), and Mean Deviation of 2.86 to double-check the risk estimate we provide.

Apellis |

Apellis Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Apellis daily returns, and it is calculated using variance and standard deviation. We also use Apellis's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Apellis Pharmaceuticals volatility.

### 30 Days Market Risk

### Chance of Distress

### 30 Days Economic Sensitivity

Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Apellis Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Apellis Pharmaceuticals at lower prices. For example, an investor can purchase Apellis stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Apellis Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

## Moving against Apellis Pharmaceuticals

- | 0.79 | MRK | Merck Company | PairCorr | |||

- | 0.78 | ASND | Ascendis Pharma AS | PairCorr | |||

- | 0.75 | BIIB | Biogen Inc | PairCorr | |||

- | 0.74 | ABBV | AbbVie Inc | PairCorr | |||

- | 0.73 | MTD | Mettler-Toledo International | PairCorr | |||

- | 0.72 | JNJ | Johnson Johnson | PairCorr | |||

- | 0.71 | A | Agilent Technologies | PairCorr |

## Apellis Pharmaceuticals Market Sensitivity And Downside Risk

Apellis Pharmaceuticals' beta coefficient measures the volatility of Apellis stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Apellis stock's returns against your selected market. In other words, Apellis Pharmaceuticals's beta of 0.37 provides an investor with an approximation of how much risk Apellis Pharmaceuticals stock can potentially add to one of your existing portfolios.

Apellis Pharmaceuticals exhibits very low volatility with skewness of -0.02 and kurtosis of 5.64. However, we advise investors to further study Apellis Pharmaceuticals technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Apellis Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Apellis Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall. 3 Months Beta |Analyze Apellis Pharmaceuticals Demand TrendCheck current 90 days Apellis Pharmaceuticals correlation with market (NYSE Composite)## Apellis Beta |

Apellis standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

## Standard Deviation | 4.24 |

It is essential to understand the difference between upside risk (as represented by Apellis Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Apellis Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in apellis stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Apellis Pharmaceuticals.

## Using Apellis Put Option to Manage Risk

Put options written on Apellis Pharmaceuticals grant holders of the option the right to sell a specified amount of Apellis Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Apellis Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Apellis Pharmaceuticals' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Apellis Pharmaceuticals will be realized, the loss incurred will be offset by the profits made with the option trade.

### Apellis Pharmaceuticals' PUT expiring on 2022-12-16

Profit |

Share

Apellis Pharmaceuticals Price At Expiration |

### Current Apellis Pharmaceuticals Insurance Chain

Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||

Put | 2022-12-16 PUT at $80.0 | -0.8331 | 0.0125 | 14 | 2022-12-16 | 28.0 - 31.1 | 0.0 | View |

Put | 2022-12-16 PUT at $75.0 | -0.9653 | 0.0074 | 14 | 2022-12-16 | 23.9 - 25.6 | 25.92 | View |

Put | 2022-12-16 PUT at $70.0 | -0.9905 | 0.0037 | 6 | 2022-12-16 | 18.7 - 20.6 | 23.0 | View |

Put | 2022-12-16 PUT at $65.0 | -0.9685 | 0.0107 | 123 | 2022-12-16 | 13.9 - 15.5 | 17.7 | View |

Put | 2022-12-16 PUT at $60.0 | -0.9264 | 0.0241 | 1888 | 2022-12-16 | 9.1 - 10.5 | 10.9 | View |

Put | 2022-12-16 PUT at $55.0 | -0.7807 | 0.0555 | 1308 | 2022-12-16 | 4.7 - 5.8 | 5.9 | View |

Put | 2022-12-16 PUT at $50.0 | -0.45 | 0.071 | 1832 | 2022-12-16 | 1.75 - 2.3 | 2.4 | View |

Put | 2022-12-16 PUT at $45.0 | -0.179 | 0.0391 | 3928 | 2022-12-16 | 0.1 - 1.0 | 0.69 | View |

Put | 2022-12-16 PUT at $35.0 | -0.025 | 0.0059 | 16758 | 2022-12-16 | 0.0 - 0.2 | 0.1 | View |

## Apellis Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which Apellis Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Apellis Pharmaceuticals' price changes. Investors will then calculate the volatility of Apellis Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Apellis Pharmaceuticals' volatility:

### Historical Volatility

This type of stock volatility measures Apellis Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Apellis Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.### Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Apellis Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Apellis Pharmaceuticals' to be redeemed at a future date.Transformation |

The output start index for this execution was zero with a total number of output elements of sixty-one. Apellis Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input..

## Apellis Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days Apellis Pharmaceuticals has a beta of 0.3675 . This suggests as returns on the market go up, Apellis Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Apellis Pharmaceuticals will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Apellis Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Apellis Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Apellis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.

The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Apellis Pharmaceuticals is significantly underperforming NYSE Composite. Predicted Return Density |

Returns |

## What Drives an Apellis Pharmaceuticals Price Volatility?

Several factors can influence a stock's market volatility:### Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.### Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.### The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.## Apellis Pharmaceuticals Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Apellis Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Apellis Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Apellis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Given the investment horizon of 90 days the coefficient of variation of Apellis Pharmaceuticals is -1149.37. The daily returns are distributed with a variance of 17.99 and standard deviation of 4.24. The mean deviation of Apellis Pharmaceuticals is currently at 2.87. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 1.49

α | Alpha over NYSE Composite | -0.31 | |

β | Beta against NYSE Composite | 0.37 | |

σ | Overall volatility | 4.24 | |

Ir | Information ratio | -0.08 |

## Apellis Pharmaceuticals Stock Return Volatility

Apellis Pharmaceuticals historical daily return volatility represents how much of Apellis Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise inherits 4.241% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 1.5033% volatility on return distribution over the 90 days horizon. Performance (%) |

Timeline |

## About Apellis Pharmaceuticals Volatility

Volatility is a rate at which the price of Apellis Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Apellis Pharmaceuticals may increase or decrease. In other words, similar to Apellis's beta indicator, it measures the risk of Apellis Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Apellis Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.

Please read more on our technical analysis page.Last Reported | Projected for 2022 | ||

Market Capitalization | 4.1 B | 3.6 B |

## Apellis Pharmaceuticals Investment Opportunity

Apellis Pharmaceuticals has a volatility of 4.24 and is 2.83 times more volatile than NYSE Composite.**36**of all equities and portfolios are less risky than Apellis Pharmaceuticals. Compared to the overall equity markets, volatility of historical daily returns of Apellis Pharmaceuticals is lower than

**36 ()**of all global equities and portfolios over the last 90 days. Use Apellis Pharmaceuticals to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of Apellis Pharmaceuticals to be traded at $62.95 in 90 days.

### Average diversification

The correlation between Apellis Pharmaceuticals and NYA is

**0.13**(i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and NYA in the same portfolio, assuming nothing else is changed.## Apellis Pharmaceuticals Additional Risk Indicators

The analysis of Apellis Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Apellis Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Apellis Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.

Risk Adjusted Performance | (0.09) | |||

Market Risk Adjusted Performance | (0.78) | |||

Mean Deviation | 2.86 | |||

Coefficient Of Variation | (1,516) | |||

Standard Deviation | 4.23 | |||

Variance | 17.92 | |||

Information Ratio | (0.08) |

Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

## Apellis Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.

The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Apellis Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Apellis Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Apellis Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Apellis Pharmaceuticals.

Please continue to Trending Equities. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

## Complementary Tools for analysis

When running Apellis Pharmaceuticals price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

CEO DirectoryScreen CEOs from public companies around the world | Go | |

Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | Go | |

Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated | Go | |

Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | Go | |

Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments | Go | |

Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | Go | |

Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device | Go | |

Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | Go |

Is Apellis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apellis Pharmaceuticals. If investors know Apellis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apellis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Market Capitalization 5.6 B | Quarterly Revenue Growth YOY 2.904 | Return On Assets (0.46) | Return On Equity (5.07) |

The market value of Apellis Pharmaceuticals is measured differently than its book value, which is the value of Apellis that is recorded on the company's balance sheet. Investors also form their own opinion of Apellis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Apellis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apellis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Apellis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Apellis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Apellis Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apellis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.